Synulox Lactating Cow Intramammary Suspension

Product Description

Synulox Lactating Cow is specially formulated for the treatment of bovine mastitis. It has a notably broad spectrum of bactericidal activity against the bacteria commonly isolated from the bovine udder. The prednisolone in Synulox Lactating Cow has an anti-inflammatory action which helps to reduce the potentially destructive swelling & inflammation associated with mastitis, without affecting the white cell response to infection. In vitro Synulox is active against a wide range of clinically important bacteria, including the following organisms, which are commonly associated with bovine mastitis: Staphylococci (including beta-lactamase-producing strains), Streptococci (including S. agalactiae, S. dysgalactiae & S. uberis), A. pyogenes & other minor members of the Corynebacteria spp. Escherichia coli (including beta-lactamase producing strains). In addition, it is active in vitro against many less common udder pathogens including: Bacillus cereus, Bacteroides (including β-lactamase producing strains) Campylobacter spp., Klebsiellae & Pasteurellae. Clinically, Synulox Lactating Cow has been shown to be an effective routine treatment for mastitis in lactating cows. Cases responding successfully to treatment include infections with the following major pathogens: Staphylococci (including β-lactamase producing strains), Streptococci (including S. agalactiae, S. dysgalactiae, & S. uberis), Escherichia coli (including β-lactamase-producing strains).